What imaging surveillance for ILD do you utilize for patients with HER2+ breast cancer receiving adjuvant T-DXd?

I follow the protocol as described in DESTINY-Breast05 (Loibl et al., PMID 41370739):

For patients who received adjuvant radiotherapy, monitoring for asymptomatic or mildly symptomatic therapy-related interstitial lung disease or pneumonitis included serial low-dose CT of the chest at 6 weeks after t...

I utilize high-resolution CT (HRCT) of the chest to monitor patients receiving adjuvant T-Dxd. Per DESTINY-Breast05, a protocol mandate, ILD surveillance with low-dose non-contrast (LDCT) was done at baseline and 6 weeks, followed by every 12 weeks during treatment and 6 weeks post-therapy completio...

I would follow the protocol for the 1st scan at 6 weeks, then every 12 weeks thereafter.